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Abstract: Atrophic glossitis is a condition characterised by absence of filiform or fungiform papillae on the dorsal surface of the
tongue. Consequently, the ordinary texture and appearance of the dorsal tongue, determined by papillary protrusion, turns into a soft
and smooth aspect.
Throughout the years, many factors, both local and systemic, have been associated with atrophic glossitis as the tongue is currently
considered to be a mirror of general health. Moreover, various tongue conditions were wrongly diagnosed as atrophic glossitis. Oral
involvement can conceal underlying systemic conditions and, in this perspective, the role of clinicians is fundamental.
Early recognition of oral signs and symptoms, through a careful examination of oral anatomical structures, plays a crucial role in
providing patients with a better prognosis.
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1. INTRODUCTION
Due  to  its  proximity  to  the  respiratory  tract  and  its  continuity  with  gastrointestinal  system,  as  well  as  its
participation  in  speech  articulation,  the  oral  cavity  assumes  a  crucial  role  in  many  physiologic  processes  [1,  2].
Additionally, a great variety of systemic disorders have been associated with specific or nonspecific oral changes and,
in many circumstances, the oral cavity becomes an important diagnostic area. Oral involvement may precede systemic
manifestations and symptoms, providing clinicians with early diagnosis of an underlying condition. In particular, its
careful examination can reveal signs and symptoms of metabolic disorders, endocrinopathies, gastrointestinal diseases,
hematologic, autoimmune, and neoplastic pathologies [1, 3].
From  this  perspective,  the  systematic  investigation  of  the  oral  mucosa  and  the  dorsum  of  the  tongue  appears
fundamental.  Any  variation  of  oral  anatomical  structures  may  be  indicative  of  a  systemic  disease  and  should  be
thoroughly  investigated.  However,  in  order  to  generate  differential  diagnoses,  since  the  aetiology  of  many  oral
conditions  remains  unknown,  defining a  univocal  classification system is  still  arduous and clinicians  should firstly
discern local and generalized systemic conditions [1 - 5]. Afterwards, having collected all clinical findings and formed a
first opinion, clinicians should determine what additional tests might be necessary before establishing the definitive
therapy.
This article focuses mainly on local and systemic conditions associated with atrophy of the dorsum of the tongue,
currently considered a potential indicator of general health. At the same time other tongue conditions, determining a
clinical aspect similar to a atrophic glossitis, will be examined in order to give a guidance to the differential  diagnosis
 In this  context, the  differential diagnosis  between primary  atrophic  glossitis  and the  conditions related  to atrophic.
*  Address  correspondence  to  this  author  at  the  Cagliari  University  Via  Ospedale,  Cagliari  Binaghi  4,  09121  Cagliari  (CA),  Italy;  Tel:  (+39)
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 tongue appears indispensable.
The ordinary texture and appearance of the dorsal tongue are related to the protrusion of a large number of papillae,
which are responsible for the roughness of the surface, (Fig. 1). Absence of filiform or fungiform papillae on the dorsal
surface of the tongue produces a soft and smooth aspect, known as atrophic glossitis (AG) [2].
Fig. (1). Graphical representation of the tongue in physiological conditions. (A. Vallate papillae, B. Foliate papillae, C. Filiform
papillae, D. Fungiform papillae).
Throughout the years, numerous factors have been taken into consideration for the aetiology of AG. In particular,
papillary atrophy has been correlated to both local and generalized systemic conditions. Local lesions are more often
attributed  to  congenital  or  developmental  affections,  infections,  neoplasia;  or  they  may  be  idiopathic.  Lesions  of
systemic origins are more frequently associated to metabolic disorders, blood dyscrasias and immunological diseases [6,
7]. AG can also be correlated with protein deficiency and a hypocaloric diet; as well as deficiency of iron, vitamin B12,
folic acid, riboflavin, and niacin [3, 8, 9].
1.1. Methodology
A literature search was done to identify all reports specifically regarding a condition of atrophy of the papillae of the
tongue, regardless of their publication status. Medline, Pubmed and Cochrane Library were searched systematically for
all published literature from January 1975 (year of the first published paper regarding the AG) to April 2016, which
included the following terms in their titles, abstracts, or keyword lists: atrophic glossitis, benign migratory glossitis and
median romboid glossitis. Reviews, case reports, editorials, letters and commentaries were excluded, as well as articles
lacking an abstract preview or not written in English.
1.2. Results
The search strategy generated 50 records for the AG, 297 records for the benign migratory glossitis and 83 records
for  the  median  romboid  glossitis.  After  application  of  the  inclusion/exclusion  criteria  and  the  analysis  of  full-text
articles,  40  records  were  discarded  for  AG,  (Fig.  2),  278  for  the  benign  migratory  glossitis  and  69  for  the  median
romboid glossitis. Finally, 10 studies for the AG, 19 studies for the benign migratory glossitis and 14 studies for the
median romboid glossitis were chosen to write the review. Due to the lack of articles that specifically deal with the
subject  of  this  review,  most  of  the  data  were  taken  from  publications  in  which  the  observation  of  tongue  atrophy
condition  was  secondary  to  the  main  outcome  of  the  work.  Additional  sources  were  hand-searched,  including:
bibliographies from previous reviews on the subject, bibliography of all publications cited in these articles and chapter
from various English textbooks regarding the oral pathology.
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Fig. (2). Study flow chart.
2. ASSOCIATIONS
The tongue is continuously exposed to chemical, mechanical and physical stimuli that, when too strong or chronic,
may cause atrophic lesions. Among these kind of aetiological factors are alcohol abuse, traumas and drug collateral
effects.  At  the  same time,  an incorrect  diet  with  nutritional  deficiency can determine atrophy of  the  dorsum of  the
tongue leading to a diagnosis of AG.
2.1. AG and Idiopathic Condition (Fissured Tongue)
Typically AG is not a physiological condition; despite this, it has been associated with another tongue disease such
as the fissured tongue, also in the absence of a systemic disease [10]. Fissured tongue is typically associated with aging
and is considered the most common lingual defect with a prevalence of 5-11% [2, 5, 10 - 13]. The principal clinical
manifestation of this condition, that is not always associated with an atrophy of the lingual dorsum, is the presence of
grooves with varying degree of depth along the dorsal surface of the tongue [10, 14]. The fissured tongue is usually
asymptomatic,  unless  a  secondary  inflammation  was  determined  by  a  low-grade  infection,  bacterial  overgrowth  or
trapped food debris. Other than being correlated with older age, this is a condition observed in patients affected by
Down's syndrome, Acromegaly, Sjogren syndrome, Psoriasis and Melkersson-Rosenthal syndrome [2, 5, 12].
2.2. AG Related to Nutritional Deficiencies
2.2.1. Introduction
The association of nutritional deficiencies and AG was first described in 1975 in the first US National Health and
Nutritional Examination Survey, and it is considered the principal aetiological factor determining the atrophy of the
tongue mucosa [2, 5, 15]. Deficiency of various nutrients, usually several of them rather than one at a time, is described
to be correlated with AG [9, 16 - 19] (Table 1). Those recognised are riboflavin (vitamin B2), niacin (vitamin B3),
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pyridoxine (vitamin B6), folic acid (vitamin B9), cobalamin (vitamin B12), iron and zinc [2, 5, 8, 9, 16, 17, 20 - 31]
(Table 2). Lately, mechanisms involving cellular oxygenation and/or the iron concentration in tongue's cells have been
associated to AG due to nutritional deficiencies. Deficiency of each one of the nutrients listed above determines one of
the conditions described, with a direct or an indirect mechanism (poor diet, malabsorption, excessive consumption).
Table 1. Literature analysis of articles focused on AG related to nutritional deficiency.
Year Author Methods Results Reference
1993 Drinka et al.
Nutritional status of 20 elderly patients with a
normal tongue and 10 subjects with various
degree of AG
Their results demonstrated a statistically significant association
between AG and deficiency of vitamin E, considered as another
nutrient responsible for the development of AG.
[16]
2000
Bøhmer and
Mowe
Nutritional status of 416 old people and the
resulting lingual alterations.
The correlation between AG and nutritional indices was statistically
significant, and related to low levels of haemoglobin, cholesterol,
ascorbic acid, serum iron and serum cobalamin.
[17]
2012 Sun et al.
Comparison of blood hemoglobin
concentration, iron, cobalamin, folic acid and
homocysteine in 176 patient with AG with
176 healthy controls
Their results showed a statistically significant association among AG
and low serum concentration of iron, vitamin B12 and haemoglobin.
Patients with AG showed high homocysteine levels.
[18]
2013 Sun et al.
Evaluation of the reduction of homocysteine
levels in 91 patients with an AG
AG healed through supplementation of different vitamins and iron [19]
2014 Wu et al.
Comparison of prevalence of AG studying
nutritional status of 75 patient with iron-
deficiency anemia and of 150 healthy
subjects.
Serum concentration of iron, vitamin B12, folic acid and homocysteine
was quantified in the blood samples of all cases. Results showed
statistically significant differences in the iron and cobalamin
concentrations between the two study groups, while no differences
were identified for the other two nutrients
[9]
2014
Demir N et
al.
Analysis of prevalence of AG in 57 neonatal
patients with vitamin B12 deficiency
Determination of a prevalence of AG of 70.17%. The authors
concluded that a deficiency of vitamin B12 should be considered in the
differential diagnosis of infants who present with skin and mucosal
lesions.
[124]
2016
Bao ZX et
al.
Analysis of serum zinc levels in 368 patients
(of which 54 had an AG).
The mean serum zinc level in the healthy control group was
significantly higher than that of the AG group.
[31]
Table 2. Nutrients associated with the determination of an AG.
Factor Name Sources Role
Disease related to the
deficiency
Vitamin B2 Riboflavin vegetables, yeast, milk Factor involved in oxidation-reduction reactions.
Normochromic
normocytic anemia
Vitamin B3 Niacin meat, beer yeast, cereals
It is involved particularly in the DNA repair process, in the
production of steroid hormones and is necessary for cellular
oxidation-reduction reactions.
Pellagra
Vitamin B6 Pyridoxin meat, vegetables
It is a cofactor in several enzymatic reactions involving the
metabolism of amino acids, glucose and lipids.
Pellagra (indirectly)
Vitamin B9 Folic acid
kidney, liver, green leafy
vegetables, legumes, eggs
Its principal biological role is related to the synthesis of DNA and
RNA and in the prevention of genetic alterations.
Megaloblastic anemia
Vitamin
B12
Cobalamin meat, milk, eggs
It is involved in the cells metabolism with several functions such
as DNA synthesis, regulatory functions of the nervous system or in
the amino acid metabolism.
Pernicious anemia
Iron Iron meat, vegetables
It carries oxygen in the hemoglobin, in the myoglobin and is also
involved in several enzymatic reactions.
Iron-deficiency anemia
Zinc Zinc
Animal-sourced foods and
some vegetables
It is involved in various biological reactions in the human body,
from cell growth to normal immune function to wound healing.
Different physiological
alterations
2.2.2. Gastrointestinal Diseases
Gastrointestinal diseases are the most common conditions associated with the development of an atrophy of the
tongue's mucosa related to a nutritional aetiology. Among them, celiac disease (CD) is considered one of the main
causes in determining the nutritional deficiencies described above [1].
Celiac disease is caused by an autoimmune intolerance to gliadin, a protein contained in gluten [32, 33]. The main
target  of  this  intolerance  is  represented  by  the  mucosa  of  the  small  intestine,  with  the  development  of  histological
lesions characterized by various degrees of villous atrophy, crypt hyperplasia, damage to the surface epithelium, an
increased number of lymphocytes and other inflammatory cells in the lamina propria [7, 32 - 34].
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This causes poor absorption of nutrients determining a deficiency of vitamin B12, folic acid and iron [34]. Tongue
lesions related to celiac diseases are identified as indirect  symptoms. The AG associated with celiac disease,  when
accompanied by other signs or symptoms, has been recognized as a warning sign of the underlying intestinal pathology
[2, 4, 7, 34 - 37]. Pastore and Lo Muzio highlighted the importance of the recognition of AG to obtain the diagnosis of a
celiac disease. The authors cited the National Institutes of Health consensus statement on celiac disease: “the single
most important step in diagnosing celiac disease is to first consider the disorder by recognizing its myriad clinical
features” [6, 38]. AG has also been described as the only clinical sign leading to suspect the diagnosis of celiac disease
[7].
In 2014, a paper by Park JM et al. described a case of Plummer-Vinson syndrome associated with Crohn's disease.
Further works will be needed to confirm this data [39].
2.3. AG by Alcohol Abuse
Alcoholic tongue atrophy can be related to two possible explanations: the status of malnutrition that characterises
alcohol abusers or a direct chemical damage to the tongue mucosa [25, 40].
Malnutrition is a typical condition of an alcoholic patient. A lack of vitamin B12/A vitamin B12 deficit in particular
is usually a sign of this malnutrition. This contradiction is due to an alteration in hepatic enzyme levels, meaning that
patients can show symptoms or signs of vitamin B12 deficiency even if its levels are normal [41]. In 2012, Cunha S.F.
et al analysed papillary atrophy of the tongue and nutritional status of hospitalized alcoholics [42]. They observed a
statistically  significant  correlation  between  atrophic  glossitis  and  reduced  anthropometric  measures,  anemia  and
hypoalbuminemia. They also identified alterations in serum levels of vitamins A, E and B12, but were not been able to
determine a correlation with an atrophic condition of the tongue [42].
Direct damage of tongue tissues caused by alcohol has been analyzed by several authors. In 1985, Valentine J.A. et
al. observed the effects of alcohol and tobacco abuse on tongue mucosa in order to identify the alteration in the lingual
epithelial structure in an antitumor evaluation [43]. The authors studied the histology of 161 tongue specimens taken
from corpses  of  patients  with  a  history  of  abuse  of  alcohol  within  5  years  before  death.  Their  results  showed  that
epithelial atrophy was frequently present on the lingual dorsum, with an increase in basal cells size and also a decrease
in superficial cells [43]. In 1994, Maier H. et al. investigated the role of alcohol as co-carcinogen. Alcohol consumption
determined a reduction of epithelial thickness associated to increased cellular proliferation in the basal layer. Alcohol
determined a cytotoxic effect, with atrophy of the oral mucosa followed by an hyper-regeneration. All these effects have
been associated with an increased susceptibility to carcinogenic substances [44, 45].
2.4. AG Related to Drugs Administration
Drugs determine an AG through several different mechanisms. The AG could derive from drug usage principally in
an indirect way, or as a symptom or consequence of a specific adverse reaction to a drug therapy [46, 47].  In fact,
specific  medicaments  can  determine  a  vitamin  deficiency  that  leads  to  an  AG through  the  mechanisms  previously
explained. The drugs with an adverse reactionleading to this kind of consequence are very different. It is possible to find
drugs for the treatment of type 2 diabetes, contraceptives, acid-lowering agents, anti-cancer medicaments, agents for the
treatment of hypertension, neurologic drugs as well as others [28, 48 - 66] (Table 1). Each one of them could generate
an  AG  related  to  a  vitamin  deficiency  through  two  principal  mechanisms  of  action:  firstly,  they  can  determine  a
malabsorption of the nutrient; secondly, they can interfere in the metabolization of a specific vitamin. In addition, there
are  other  mechanisms leading  to  an  atrophic  condition  such  as  the  development  of  candidiasis  after  antibiotic  use,
xerostomia related to antidepressant consumption or microcirculation alteration after use of chemotherapeutical drugs
[67 - 73]. In addition, a review from 2012 described as a tongue dysesthesia can also be associated with multitargeted
tyrosine kinase inhibitors (TKIs) and mammalian target of rapamycin inhibitors (mTORIs) [74].
2.5. AG as Consequence of Infectious Disease
Tongue crypts, along with tonsils and gingival sulcus, are considered important ecological niches of the oral cavity
[75].  In  these  areas  the  balance  between  the  environment  and  oral  microorganisms  is  frail,  and  regulates  the
maintenance  of  the  oral  ecosystem  equilibrium  preventing  environmental  changes  [76  -  78].
The tongue dorsum is always colonized by various microbial colonies without the development of a pathological
condition. When the balance of the niches is altered, it is often possible to observe a pathological colonization due to a
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specific, and often single, microbial strain accompanied by clinical manifestations. Atrophic condition of the tongue has
been described in association with candidiasis, colonization of Helicobacter pylori and as consequence of Treponema
pallidum infection [2, 12, 79 - 81].
2.5.1. Candida Albicans
Candida albicans (C. albicans) is one of the normal components of microflora of the oral cavity, with a prevalence
between the 30 and the 50% [82]. The development of an oral candidiasis is usually related to an imbalance of the
normal oral microbial ecosystem. Determinants of an oral candidiosis are: long-term antibiotic therapy, use of local
steroids (i.e. inhaler or mouthwashes), immunodeficiencies (i.e. AIDS, organ transplant, chemotherapy) or favourable
environmental conditions (i.e. xerostomia, poor oral hygiene, diabetes) [83 - 86]. Candida infection promotes different
clinical manifestations on the tongue surface, both acute and chronic. Among them, chronic erythematous candidiasis
determines an atrophic lesion defined as median rhomboid glossitis [5, 70], while an acute erythematous candidiasis can
promote an a specific AG [79].
2.5.2. Helicobacter Pylori
Helicobacter pylori (H. pylori) is a Gram-negative, microaerophilic bacterium identified among etiologic factors
contributing to chronic gastritis and gastric ulcers [87]. Its presence in oral plaque and saliva is controversial, in several
studies prevalence fluctuated from 0 to 100% [88 - 91]. In 2001, Gall-Troselj et al. examined the possible role of H.
pylori in determining an AG and the burning mouth syndrome [81]. They examined 87 patients with an AG looking for
the presence of H. pylori  by cytobrash of the dorsal  tongue mucosa.  Their  results  showed a high prevalence of the
bacteria of tongues in patients affected by the AG (16%) compared with healthy controls (0%). This statistically higher
incidence lead the authors to suspect that H. pylori colonization could have been secondary to the development of the
AG,  and  not  its  causative  agent.  They  hypotized  a  change  in  salivary  flow  and/or  salivary  content  prior  to  the
development of the AG [81].
2.5.3. Treponema Pallidum (Syphilis)
Treponema pallidum is an anaerobic spirochete causing the sexually transmitted systemic disease named syphilis.
Oral manifestations are uncommon but can be present in all the three stages of the disease. The importance of mouth
examination for the diagnosis has been recognized long ago [92].
The review analyzing the literature from 1950 to 2011 about oral manifestation of syphilis, determined the atrophic
condition of the tongue as the sign of a secondary and tertiary stages of the disease. In particular, tongues were shown to
be affected in 37% of cases, while the prevalence of the atrophic conditions is not clear [93].
2.6. Atrophic Tongue Condition as Consequence of Systemic Diseases
An atrophic condition of the tongue can be related to a systemic disorder that leads to nutritional deficiency, with
the  determination  of  an  AG as  described  in  2.2.  section,  to  direct  damage  following  autoimmunity  mechanisms  or
through neoplastic degeneration that brings to an atrophic aspect of the tongue, but that doesn't determine a diagnosis of
AG.
There are several other systemic conditions or pathologies that can lead to the formation of an atrophic aspect of the
tongue, not always classifiable as AG: autoimmune diseases, pre-neoplastic and neoplastic conditions, direct damage,
genetic pathologies and metabolic disorders [1, 3, 12].
2.6.1. Gastroesophageal Reflux
Gastroesophageal reflux disease (GERD) is a pathological condition typically represented by the regurgitation of
gastric acid with damage to the esophagus. Symptoms of GERD are distinguished into classic and extra-esophageal, the
latter being the only symptoms in about fifty percent of cases [94]. Oral signs can be distinguished on the basis of their
aetiological cause. Direct damage provoked by gastric acid reflux from the stomach is represented mainly by dental
erosions [95]. Mucosal damages, in particular on the palatine mucosa, are often described as hyperaemic, erythematous
areas along with an alteration in salivary gland functions. Atrophic lesions of the tongue are frequently described in
association with GERD. It is often difficult to determine if they are a direct consequence of the acid ph or if they are
secondary to the alteration of the saliva (often with a xerostomic condition) leading to infection (e.g. candidiosis) or,
more frequently, originating from drug administration (see Table 3) [95, 96].
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Table 3. Drugs that could be related to the development of an atrophic condition of the tongue.
Drug name Application
Side effect potentially producing an atrophic
tongue
Ref
Metformin Type 2 diabetes treatment
Vitamin B12 and folic acid deficiency (in
association with proton-pump inhibitor)
[60]
Proton-pump inhibitor (omeoprazole,
lansoprazole)
Acid-lowering agent
Vitamin B12 deficiency (in association with
metformin)
[53]
Histamine antagonist Acid-lowering agents Vitamin B12 deficiency [61]
Isoniazid Anti-tuberculosis agent Vitamin B3 and vitamin B6 deficiency [49]
Chloramphenicol Antibiotic Vitamin B3 deficiency [58]
Fluorouracil Cancer treatment (antimetabolite) Vitamin B3 deficiency [69]
Oral contraceptives Contraceptive Vitamin B6 and folic acid deficiency [54]
Anticonvulsants (carbamazepine,
valproic acid, gabapentin,
phenobarbital, phenytoin and
primidone)
Treatment of epilepsy and neuropathic pain Vitamin B6 and folic acid deficiency [59]
Cycloserine Anti-tuberculosis agent Vitamin B6 deficiency [62]
Penicillamine Immunosuppression to treat rheumatoid arthritis Vitamin B6 deficiency [63]
Hydrocortisone Immune system suppression Vitamin B6 deficiency [48]
Mercaptopurine Immunesuppressive agent Vitamin deficiency [64]
Methotrexate Treatment of cancer and autoimmune diseases Folic acid deficiency [65]
Sulfasalazine Rheumatoid arthritis treatment Folic acid deficiency [66]
Triamterene Treatment of hypertension and edema Folic acid deficiency [67]
Chemotherapy Cancer treatment Changes of oral microcirculation [69, 70]
Bleomycin Cancer treatment Tissutal hypoxia [69, 70]
Bisphosphonates (alendronate,
etidronate and risedronate)
Metastatic prevention, treatment of osteoporosis
and arthritis rheumatoid
Xerostomia, alteration of cellular turnover [72]
Antidepressants (clomipramine,
doxepin)
Tricyclic antidepressants Xerostomia, anemia (rare) [73]
Fluoxetine Antidepressant Xerostomia, gastrointestinal disorders [68]
Venlafaxine Antidepressant Xerostomia, gastrointestinal disorders [68]
Fluvoxamine
Treatment of obsessive-compulsive disorder and
major depressive disorder
Xerostomia, gastrointestinal disorders [68]
Serteraline Antidepressant
Gastrointestinal disorders determining
malabsorption
[68, 73]
Antibiotics Antibacterial activity Candidiasis, gastrointestinal disorders [48]
Rivastigmine
Treatment of dementia of the Alzheimer’s type and
dementia due to Parkinson's disease.
Gastrointestinal disorders [74]
Sulfonamides Various Hemolytic anemia [48]
Trihexyphenidyl Antiparkinsonian agent Xerostomia [48]
2.6.2. Lichen Planus
Lichen planus is a chronic dermatologic disease that often affects the oral mucosa with two clinical manifestations:
reticular and erosive [3, 97, 98]. Erosive lichen is less common than the reticular one, but it is clinically more important
because is often symptomatic. The lesion appear as atrophic, erythematous areas with central erosion of varying degrees
[3, 97, 98]. The tongue, the third or fourth oral site are more frequently involved after the buccal mucosa, lower lip and,
sometime, the gingiva [99]. It is suggested to perform a biopsy in cases in which diagnosis is doubtful (Fig. 3).
2.6.3. Neoplastic Conditions
Squamous cell carcinoma of the tongue is the cancer more frequently diagnosed in the oral cavity, with an incidence
between 25 and 40% [100]. This condition is strictly related to the abuse of tobacco and alcohol, and more frequently
involves the lateral surface of the tongue [2, 100, 101]. Cancer of the tongue clinically appears as a nodular or ulcerated
lesion frequently associated with pain and discomfort. In the premalignant phase, the tongue shows a red or white lesion
that leads to the diagnosis of an erythroplakia or a leukoplakia [2]. The erythroplakia is a condition that can determine a
misdiagnosis of AG, with the risk of delayed recognition of the tumour [2, 12]. A biopsy is fundamental for the correct
diagnosis and subsequent therapy [102].
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Fig. (3). Tongue lesion related to lichen planus (histological diagnosis).
2.6.4. Riley-Day Syndrome
First described in 1949 by Conrad Milton Riley and Richard Lawrence Day, this disorder is an autosomal recessive
neuropathy of the autonomic nervous system [103, 104]. It is characterised by decreased deep tendon reflexes, impaired
perception  of  temperature  and  pain,  lack  of  an  axon  flare  following  intradermal  histamine  injection,  labile  blood
pressure and absence of fungiform and filiform papillae in the tongue [5, 12, 105]. This pathology exclusively affects
Ashkenazi Jewish children, and presents several oral signs with high rates of dental trauma and self-mutilations. AG
represents  the  most  important  oral  sign  that  can  lead  to  a  suspicion  of  the  underlying  syndrome and  is  based  on  a
degenerative condition caused by a local autoimmune reaction [104].
2.6.5. Psoriasis
Psoriasis is a skin and joint disease affecting between 1 and 2% of the population of the United States [3]. The
clinical  pattern  is  represented  by  an  increased  proliferation  of  keratinocytes  due  to  an  autoimmune  reaction,  with
activation of T lymphocytes, abnormal production of cytokines, altered molecular adhesion, chemotactic mechanisms
and grow factors productions [3]. Specific oral lesions have been associated with this pathology. In particular, fissured
tongue and geographical tongue have been observed as consequence of the immunological disorder [106]. Oral mucosal
lesion may be associated with psoriasis, but it is not clear if these can be considered pathognomonic of this systemic
disease [104].
2.6.6. Epidermolysis Bullosa
Epidermolysis bullosa (EB) is a rare genetic disorder represented by various and different subtypes, all based on a
fragility of  skin and mucosal  membranes with the development of  blisters  and atrophic areas.  A strong association
between this systemic disease and tongue affections has been described. More than the 50% of patients involved in a
study presented AG in various degrees of severity, so that the tongue has been considered the most affected oral site in
patients with diagnosed EB [107]. Lingual involvement has also been described by other authors, confirming that the
lingual dorsum is the oral site with the most frequent manifestations. Unfortunately, oral lesions are not pathognomonic
of EB or of EB sub-types [108 - 110]. It is hypothesized that the high prevalence of tongue affection can be explained
by its size, function and position, so that it is constantly exposed to the risk of traumas [107].
2.6.7. Melkersson-rosenthal Syndrome
The  Melkersson-Rosenthal  syndrome  (MRS)  is  a  rare  granulomatous  disease  characterised  by  vesicles,
lymphangiomas, facial paralysis and fissured tongue [3, 111, 112]. Tongue lesions were described in a large number of
patients,  arriving up to  75% in a  study by Feng et  al.  In  the  MRS there  is  an alteration of  the  microcirculation,  in
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addiction  to  food  intolerance  determining  malabsorption  [113  -  116].  The  tongue  can  develop  fissures,  edema,
paresthesia, erosions or taste alteration [3, 111, 112]. For the reasons explained previously, in addition to the therapy
with corticosteroid, clinicians often suggest a specific diet, with the addition of B vitamins. Therefore, the application of
tests to determine food allergies will make it easier to identify and eliminate particular foods from a given patient’s diet
[113].
2.6.8. Diabetes
Diabetes  mellitus  is  a  disease  that  causes  an  alteration  in  the  production  of  insulin  or  that  determines  a  tissue
resistance to insulin effects [3]. It is divided into two different clinical patterns (Type I and type II). Only type I diabetes
is  related  to  oral  manifestation  through  autoimmune  aetiology.  Oral  manifestations  are  periodontitis,  diabetic
sialoadenosis,  oral  candidiasis,  xerostomia,  fissured  tongue  and  benign  migratory  glossitis  [3,  14,  117  -  119].
Candida  infections,  in  particular  the  development  of  a  median  rhomboid  glossitis,  are  strongly  associated  with
diabetes mellitus, with an incidence up to 30% of patients [3, 70, 79].
Fissured tongue and benign migratory glossitis were described as common finding in diabetic patients, but a definite
correlation has never been recognized [3, 117, 120, 121].
3. DIAGNOSTIC HINTS
The diagnosis of an atrophic condition of the tongue is complicated by the similar, local expression of different
clinical presentations. It is usually composed of three different clinical patterns, such as atrophic glossitis, geographic
tongue (benign migratory glossitis) and the median rhomboid glossitis (Table 4).
Table 4. Summary of the different kind of atrophic disease of the tongue.
Diagnosis Epidemiology Aetiology Symptoms Treatment
Median Rhomboid
glossitis
It affects 0.001%-1% of the
population
Candida infection
Usually asymptomatic,
burning or itching possible
Application of antifungal medicaments
Geographic
tongue/benign migratory
glossitis
Prevalence range from 1%
to 2.5%
Unknown
Often asymptomatic,
sometimes burning
sensation
None, if associated with burning mouth
syndrome it is possible to apply topical
steroid
Atrophic glossitis Incidence between 1.3-9%
Nutritional
defiencies or
underlying disease
Asymptomatic
Treatment of the systemic disease (if
present) and administration of nutritional
supplement (see Table 1)
Fig. (4). Atrophic glossitis related to a celiac disease (histological diagnosis).
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3.1. Atrophic Glossitis
Reamy et al. in 2010 described this clinical as: “Atrophic glossitis is also known as smooth tongue because of the
smooth, glossy appearance with a red or pink background. The smooth quality is caused by the atrophy of filiform
papillae [2],” (Fig. 4). As previously described, the real AG is typically related to a nutritional deficiency status. The
lack of vitamin intake can be associated with a poor diet or with a systemic disease. In both cases a blood sample is
necessary to identify an alteration in hemoglobin, iron, folic acid and vitamin B group and homocysteine levels,  in
addition to gastric parietal cell antibody positivity [9, 18, 19, 122]. It can also be useful to perform antigliadin, tissue
transglutaminase  and  the  IgA-endomysial  antibody  tests,  and  a  microbiological  analysis  of  tongue  surface  [7,  18].
Sometimes, the absence of symptoms makes the diagnosis more difficult because patients are often non-compliant with
all the required exams.
3.2. Geographic Tongue/Benign Migratory Glossitis
This disease has been defined as: “[...] the dorsal tongue develops areas of papillary atrophy that appear smooth
and are surrounded by raised serpiginous borders. These regions of atrophy spontaneously resolve and migrate, giving
the tongue a variegated appearance [2].” The diagnosis of this condition is easy, because of the tendency of the lesions
to change and “move” throughout the day. Two repeat visits in 12-24 hours and a microbiological examination to rule
out a Candida infection, will help in identifying with sufficient certainty the disease without the need for further tests
[12, 79, 123]. It is often impossible to alleviate patients’ burning sensations. A simple search for nutritional deficiencies
is strongly recommended [124].
3.3. Median Rhomboid Glossitis
This pathology is described as “[...] a smooth, shiny, erythematous, sharply circumscribed, asymptomatic, plaque-
like lesion on the dorsal midline of the tongue [2],” (Fig. 5). Clinically it can be asymptomatic or it can determine pain
or burning sensation. The aetiology of this disease is controversial, but it is usually considered as a clinical variant of a
candida infection. A microbiological analysis of tongue surface and a thorough anamnesis are key to diagnosis [86].
4. DISCUSSION
The tongue can be considered as a mirror of oral and/or systemic health. An oral medicine expert can be the first to
observe the lingual status, and should be familiar with the different diagnoses of these conditions, for example being
able  to  link  lingual  abnormalities  with  specific  etiologic  causes.  Recognition  of  alterations  relative  to  tongue’s
morphology, in the presence of a negative anamnesis, should lead to more accurate investigations, in order to ascertain
if they are manifestations of an underlying systemic condition [1, 12].
Fig. (5). Median rhomboid glossitis (Microbiological diagnosis).
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Among  tongue  diseases,  AG has  the  most  complex  differential  diagnosis,  because  it  is  associated  with  several
conditions. Atrophy of the filiform papillae, not directly attributable to mechanical damages of the mucosa, can occur in
systemic or local conditions. Although seemingly simple, sometimes the recognition of a “real AG” can be very hard.
Many local conditions, such as median rhomboid glossitis, of glossite migrans, mediated by infective and idiopathic
etiological factors, as well as neoplastic or congenital factors, can complicate the diagnosis. Reamy et al. described and
analyzed the most frequent lingual diseases, with a particular attention to the atrophic conditions [2]. They summarized
the  etiologic  conditions  responsible  for  the  development  of  AG;  among  them  it  was  discovered  that  nutritional
deficiencies and drug reactions are the most frequently encountered. Unfortunately, while drug interactions are almost
always detectable with anamnesis, nutritional deficiencies can be related to various and different systemic conditions,
and sometimes the etiological factor may be difficult to identify. A typical example is anaemia, in which the cause may
be acute or chronic. In some circumstances, however, the outbreak of other symptoms in association with the casual
discovery of tongue lesions, as in case of celiac disease, can be decisive for the diagnosis [7].
The clinician has to identify the clinical and anamnestic conditions that will lead to the diagnosis of the AG and also
identify a possible related systemic disease. During the first observation of the lesion it is necessary to apply a strict
protocol  to  achieve  the  right  diagnosis.  First  of  all,  after  the  anamnesis,  the  clinician  has  to  identify  if  the  lingual
condition can be associated with medication taken by the patient (Table 2) or with some already recognised systemic
disease (chapter 2.3). In case of a negative anamnesis, it is fundamental to verify if the AG changes during the 12-24
hours after the first  observation in order to reject the hypothesis of a geographic tongue (chapter 3.2).  If  the lesion
shows no variation in this time-span, the clinician needs to perform a microbiological analysis of the lingual dorsum to
exclude  or  find  a  candida  infection  (that  can  be  classified  as  primary  or  secondary  to  the  AG).  The  presence  of  a
candidiasis is not necessarily the diagnostic answer, because the AG can easily be infected by both local and systemic
conditions. It is important to remember that the clinical picture associated with a primary candidiasis is the median
rhomboid  glossitis  (chapter  3.3),  while  condition  such  as  nutritional  deficiencies,  diabetes,  xerostomia  and  ph
alterations  can  easily  lead  to  a  secondary  infection.  Anyway,  in  case  of  positivity  of  the  microbiological  test,  it  is
necessary to treat the infection and to revaluate the patient after the therapy, repeating the microbiological analysis in
order  to  observe  possible  remission  of  the  atrophic  condition  (in  case  of  primary  candidiasis).  If  the  lesion  is  still
observable  after  the  antimicrobic  therapy,  or  in  case  the  microbiological  test  was  negative,  the  clinician  needs  to
evaluate specific blood tests (chapter 3.1). Following the results of the blood tests, the pathologist should be able to
identify the aetiology of the atrophic condition and to treat  it,  or  ask for a consultation.  In the case of unknown or
unidentified aetiology, the observation has to be repeated to identify the appearance of other signs (local or systemic).
CONCLUSION
The  early  recognition  of  signs  and  symptoms  relative  to  systemic  conditions  through  careful  analysis  of  oral
anatomical  structures  appears  essential  in  the  perspective  of  achieving  a  better  prognosis.  Atrophic  anomalies  are
related to several  conditions,  both local  and systemic,  that  clinicians have to know and identify.  For these reasons,
knowledge of oral diseases and their aetiology is important, requiring a continuous professional education as well as
interaction with other medical specialists when necessary.
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